Your browser doesn't support javascript.
loading
Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature.
Takeshita, Akihiro; Asou, Norio; Atsuta, Yoshiko; Furumaki, Hiroaki; Sakura, Toru; Ueda, Yasunori; Sawa, Masashi; Dobashi, Nobuaki; Taniguchi, Yasuhiro; Suzuki, Rikio; Nakagawa, Masaru; Tamaki, Shigehisa; Hagihara, Maki; Fujimaki, Katsumichi; Minamiguchi, Hitoshi; Fujita, Hiroyuki; Yanada, Masamitsu; Maeda, Yoshinobu; Usui, Noriko; Kobayashi, Yukio; Kiyoi, Hitoshi; Ohtake, Shigeki; Matsumura, Itaru; Naoe, Tomoki; Miyazaki, Yasushi; Group, The Japan Adult Leukemia Study.
Affiliation
  • Takeshita A; Transfusion and Cell Therapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Higashiku 431-3192, Japan.
  • Asou N; International Medical Center, Saitama Medical University, 1397-1, Yamane, Hidaka 350-1298, Japan.
  • Atsuta Y; The Japanese Data Center for Hematopoietic Cell Transplantation, 1-1-20 Taikou-minami, Higashiku, Nagoya 461-0047, Japan.
  • Furumaki H; Transfusion and Cell Therapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Higashiku 431-3192, Japan.
  • Sakura T; Hematology, Saiseikai Maebashi Hospital, 564-1, Kamishindenmachi, Maebashi 371-0821, Japan.
  • Ueda Y; Hematology/Oncology, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki 710-8602, Japan.
  • Sawa M; Hematology and Oncology, Anjo Kosei Hospital, 28 Higashikurokute, Anjochou, Anjo 446-8602, Japan.
  • Dobashi N; Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishisinbashi, Minatoku, Tokyo 105-8461, Japan.
  • Taniguchi Y; Hematology and Rheumatology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Ohsakasayama 589-8511, Japan.
  • Suzuki R; Hematology and Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isahara 259-1193, Japan.
  • Nakagawa M; Hematology and Rheumatology, Nihon University School of Medicine, 30-1 Ohyaguchikamichou, Itabashiku, Tokyo 173-8610, Japan.
  • Tamaki S; Hematology, Japanese Red Cross Ise Hospital, 1-471-2 Funae, Ise 516-8512, Japan.
  • Hagihara M; Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawaku, Yokohama 236-0004, Japan.
  • Fujimaki K; Hematology, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa 251-8550, Japan.
  • Minamiguchi H; Hematology, Shiga University of Medical Science, Seta-Tsukinowa, Otsu 520-2192, Japan.
  • Fujita H; Hematology, Saiseikai Yokohama Nanbu Hospital, 3-2-10 Kounandai, Kounanku, Yokohama 234-0054, Japan.
  • Yanada M; Hematology and Cell Therapy, Aichi Cancer Center, 1-1 Kanokoden, Chikusaku, Nagoya 464-8681, Japan.
  • Maeda Y; Hematology, Oncology and Respiratory Medicine, Okayama University Medical School, 2-5-1 Shikatachou, Kitaku, Okayama 700-8558, Japan.
  • Usui N; Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishisinbashi, Minatoku, Tokyo 105-8461, Japan.
  • Kobayashi Y; National Cancer Center Hospital, 5-1-1 Tsukiji, Chuouku, Tokyo 104-0045, Japan.
  • Kiyoi H; Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumaichou, Showaku, Nagoya 466-8550, Japan.
  • Ohtake S; Kanazawa University, Kakumamachi, Kanazawa 920-1192, Japan.
  • Matsumura I; Hematology and Rheumatology, Kindai University Faculty of Medicine, 377-2 Ohnohigashi, Ohsakasayama 589-8511, Japan.
  • Naoe T; National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Nakaku, Nagoya 460-0001, Japan.
  • Miyazaki Y; Hematology, Atomic Bomb Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
  • Group TJALS; JALSG office, 3-6-35 Nishiki, Nakaku, Nagoya 460-0003, Japan.
Cancers (Basel) ; 12(6)2020 Jun 01.
Article in En | MEDLINE | ID: mdl-32492981

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cancers (Basel) Year: 2020 Document type: Article Affiliation country: Country of publication: